» Articles » PMID: 11307592

Penicillium Marneffei: Types and Drug Susceptibility

Overview
Journal Mycopathologia
Date 2001 Apr 20
PMID 11307592
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The PCR fingerprints of 30 Penicillium marneffei isolates from Chiang Rai in Northern Thailand and Bangkok in central Thailand were studied through use of single-nucleotide primers (GACA)4 and the phage M13 core sequence. Discrimination of fingerprint patterns was based on differences in the number of major bands. The P. marneffei isolates were divided into four types, i.e., A, B, C, and D. Type A was found in two isolates from Chiang Rai (6.7%). Types B and C respectively were found in two (6.7%) and one (3.3%) isolates from Bangkok. The predominate type D (83.3%) was found in isolates obtained from Chiang Rai and Bangkok. The PCR fingerprinting method was found to be useful for the epidemiological study of P. marneffei, a dimorphic opportunistic fungus and an emerging pathogen in the HIV pandemic. In vitro drug susceptibility testing by broth macrodilution to four antifungal agents against the yeast form of P. marneffei was performed. The MIC ranges for amphotericin B, fluconazole, itraconazole, and ketoconazole were 0.125-0.5, 4.0-8.0, < 0.032, and < 0.125 microgram/ml respectively.

Citing Articles

Development and validation of a colorimetric antifungal susceptibility testing method for the dimorphic fungus Talaromyces marneffei.

Thu N, Borda H, Vitsupakorn S, Sreerama Reddy K, Kasmani N, Barwatt J Med Mycol. 2023; 61(11).

PMID: 37994652 PMC: 10681740. DOI: 10.1093/mmy/myad111.


Bioaerosol assessment in indoor and outdoor environments: a case study from India.

Jabeen R, Kizhisseri M, Mayanaik S, Mohamed M Sci Rep. 2023; 13(1):18066.

PMID: 37872255 PMC: 10593752. DOI: 10.1038/s41598-023-44315-z.


An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease.

Zaongo S, Zhang F, Chen Y J Fungi (Basel). 2023; 9(6).

PMID: 37367583 PMC: 10301665. DOI: 10.3390/jof9060647.


An Overlooked and Underrated Endemic Mycosis-Talaromycosis and the Pathogenic Fungus Talaromyces marneffei.

Wang F, Han R, Chen S Clin Microbiol Rev. 2023; 36(1):e0005122.

PMID: 36648228 PMC: 10035316. DOI: 10.1128/cmr.00051-22.


Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.

Cao C, Xi L, Chaturvedi V Mycopathologia. 2019; 184(6):709-720.

PMID: 31811603 DOI: 10.1007/s11046-019-00410-2.


References
1.
Odds F, Abbott A . Modification and extension of tests for differentiation of Candida species and strains. Sabouraudia. 1983; 21(1):79-81. DOI: 10.1080/00362178385380111. View

2.
Sekhon A, Garg A, Padhye A, Hamir Z . In vitro susceptibility of mycelial and yeast forms of Penicillium marneffei to amphotericin B, fluconazole, 5-fluorocytosine and itraconazole. Eur J Epidemiol. 1993; 9(5):553-8. DOI: 10.1007/BF00209535. View

3.
Mitchell T, Freedman E, White T, Taylor J . Unique oligonucleotide primers in PCR for identification of Cryptococcus neoformans. J Clin Microbiol. 1994; 32(1):253-5. PMC: 263011. DOI: 10.1128/jcm.32.1.253-255.1994. View

4.
Supparatpinyo K, Chiewchanvit S, Hirunsri P, Uthammachai C, Nelson K, Sirisanthana T . Penicillium marneffei infection in patients infected with human immunodeficiency virus. Clin Infect Dis. 1992; 14(4):871-4. DOI: 10.1093/clinids/14.4.871. View

5.
Yuen W, Chan Y, Loke S, Seto W, Poon G, Wong K . Chronic lymphadenopathy caused by Penicillium marneffei: a condition mimicking tuberculous lymphadenopathy. Br J Surg. 1986; 73(12):1007-8. DOI: 10.1002/bjs.1800731224. View